SALT Holding Corp’s AstraZeneca AZN Stock Holding History

SALT Holding Corp’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.4M	Hold	93,250	–	–	11.11%	3
2025 Q4	$17.1M	Buy	93,250 +84,650	+984%	+$14.8M	13.29%	3
2025 Q3	$1.32M	Buy	+8,600	New	+$1.3M	1.23%	9
2025 Q2	–	Sell	-7,600	Closed	-$1.12M	–	9
2025 Q1	$1.12M	Hold	7,600	–	–	1.04%	7
2024 Q4	$996K	Buy	+7,600	New	+$1.06M	1.22%	8

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

SALT Holding Corp's AZN Position: Q1 2026 in Review

SALT Holding Corp held its AstraZeneca (AZN) position steady in Q1 2026 at 93,250 shares worth $18.4M. The position accounts for 11.11% of the portfolio, ranked #3.

SALT Holding Corp first reported a position in AZN in Q4 2024 and has held it in 5 quarters since. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

SALT Holding Corp held 93,250 shares of AstraZeneca worth $18.4M as of Q1 2026.
SALT Holding Corp left its AstraZeneca share count unchanged in Q1 2026.
AstraZeneca made up 11.11% of SALT Holding Corp's portfolio in Q1 2026, its #3 holding.
SALT Holding Corp first reported a position in AstraZeneca in Q4 2024 and has held it in 5 quarters since.
1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on SALT Holding Corp's 13F filing for Q1 2026, filed 15 May 2026.